Literature DB >> 27914788

Claudin-6 enhances cell invasiveness through claudin-1 in AGS human adenocarcinoma gastric cancer cells.

A C Torres-Martínez1, J F Gallardo-Vera1, A N Lara-Holguin1, L F Montaño1, E P Rendón-Huerta2.   

Abstract

Claudins participate in tissue barrier function. The loss of this barrier is associated to metalloproteases-related extracellular matrix and basal membranes degradation. Claudin-1 is a pro-MMP-2 activator and claudin-6 transfected AGS (AGS-Cld6) cells are highly invasive. Our aim was to determine if claudin-6 was direct or indirectly associated with MMP-2 activation and cell invasiveness. Cytofluorometry, cell fractioning, immunoprecipitation, gelatin-zymography, cell migration and invasiveness assays were performed, claudin-2, -6, -7 and -9 transfected AGS cells, anti-MMP-2, -9 and -14, anti-claudins specific antibodies and claudin-1 small interfering RNA were used. The results showed a significant (p<0.001) overexpression of claudin-1 in AGS-Cld6 cell membranes. A strong MMP-2 activity was identified in culture supernatants of AGS-Cld6. Claudin-1 co-localized with MMP-2 and MMP-14; interestingly a significant increase in cell membrane and cytosol MMP-14 expression was detected in AGS-Cld6 cells (p<0.05). Silencing of claudin-1 in AGS-Cld6 cells showed a 60% MMP-2 activity decrease in culture supernatants and a significant decrease (p<0.05) in cell migration and invasiveness. Our results suggest that claudin-6 induces MMP-2 activation through claudin-1 membrane expression, which in turn promotes cell migration and invasiveness.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Claudin; Cldn-1; Cldn-6; MMP-14; MMP-2

Mesh:

Substances:

Year:  2016        PMID: 27914788     DOI: 10.1016/j.yexcr.2016.11.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

Review 1.  Non-canonical functions of claudin proteins: Beyond the regulation of cell-cell adhesions.

Authors:  Susan J Hagen
Journal:  Tissue Barriers       Date:  2017-05-19

2.  Claudin-6 increases SNAI1, NANOG and SOX2 gene expression in human gastric adenocarcinoma AGS cells.

Authors:  Priscila Anhel Medrano-Gonzálezl; Franklin Cruz-Villegas; Alejandro Alarcón Del Carmen; Luis Felipe Montaño; Erika Patricia Rendón-Huerta
Journal:  Mol Biol Rep       Date:  2022-09-28       Impact factor: 2.742

Review 3.  Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature.

Authors:  Wenjie Peng; Pei Wu; Minghao Yuan; Bo Yuan; Lian Zhu; Jiesong Zhou; Qian Li
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

Review 4.  Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

Authors:  Ajaz A Bhat; Srijayaprakash Uppada; Iman W Achkar; Sheema Hashem; Santosh K Yadav; Muralitharan Shanmugakonar; Hamda A Al-Naemi; Mohammad Haris; Shahab Uddin
Journal:  Front Physiol       Date:  2019-01-23       Impact factor: 4.566

Review 5.  Tight Junction Proteins and the Biology of Hepatobiliary Disease.

Authors:  Natascha Roehlen; Armando Andres Roca Suarez; Houssein El Saghire; Antonio Saviano; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

6.  A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.

Authors:  Yiyang Jia; Yantong Guo; Qiu Jin; Huinan Qu; Da Qi; Peiye Song; Xiaoli Zhang; Xinqi Wang; Wenhong Xu; Yuan Dong; Yingying Liang; Chengshi Quan
Journal:  J Exp Clin Cancer Res       Date:  2020-02-24

7.  The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma.

Authors:  Qing Lv; Qinghua Xia; Anshu Li; Zhiyong Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 8.  Intestinal Barrier, Claudins and Mycotoxins.

Authors:  Marta Justyna Kozieł; Maksymilian Ziaja; Agnieszka Wanda Piastowska-Ciesielska
Journal:  Toxins (Basel)       Date:  2021-10-26       Impact factor: 4.546

Review 9.  CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers.

Authors:  Huinan Qu; Qiu Jin; Chengshi Quan
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.